期刊文献+

原始神经外胚层肿瘤手术及综合治疗患者预后相关因素分析 被引量:4

Prognostic factors of patients with primitive neuroectodermal tumor after surgery and multimodal treatment
下载PDF
导出
摘要 目的分析原始神经外胚层肿瘤(primitive neuroectodermal tumor,PNET)术后患者的综合治疗疗效及影响预后的相关因素。方法回顾性分析我院2008年6月-2014年12月收治的41例PNET术后患者,其中男24例,女17例,年龄4-65岁,中位年龄24岁。中枢性PNET 6例,外周性PNET 35例,肿瘤原发灶位于四肢8例,颅内及头面部10例,椎管内及椎旁4例,胸部5例,腹腔7例,盆腔7例。单纯手术2例,手术+化疗22例,手术+放疗4例,手术+化疗+放疗13例。结果全组中位生存期为38个月,1年、3年、5年总生存率分别为87.8%、51.9%、37.1%,1年、2年无进展生存率分别为41.3%、29%。26例术后局部复发(63.4%)。单因素分析显示,术后局部复发、手术切除不完整是影响PNET患者预后的不良因素;而局部放疗可以改善PNET术后患者的预后。多因素分析显示,手术完整切除和手术+化疗+放疗联合治疗为PNET术后患者长期生存的独立影响因素(P=0.006、0.013)。结论 PNET治疗仍推荐手术+化疗+放疗的综合治疗方案。术后局部复发严重影响患者的预后。手术完整切除的患者预后较好。 Objective To evaluate the multimodal treatment outcomes and prognostic factors of patients with primitive neuroectodermal tumor(PNET) after surgery. Methods Clinical data about 41 patients who were diagnosed with PNET in Chinese PLA General Hospital from June 2008 to December 2014 were retrospectively analyzed. There were 24 males and 17 females with the median age of 24 years(ranging from 4 to 65 years). Of the 41 cases, 6 patients were c PNET and 35 patients were p PNET. Original sites included limbs(n=8), brain and head(n=10), spinal canal and paravertebral site(n=4), chest(n=5), abdomen(n=7) and pelvis(n=7). All patients had undergone surgical treatment, including 2 cases with surgery alone, 22 patients with surgery and chemotherapy, 4 patients with surgery and radiotherapy, and 13 patients with surgery, radiotherapy and chemotherapy. Results The overall median survival time was 38 months. The overall survival(OS) rates of 1-year, 3-year and 5-year were 87.8%, 51.9% and 37.1%, respectively. The progression-free survival(PFS) rates of 1- and 2-year were 41.3% and 29%. Twenty-six patients had relapse of this disease(63.4%). Univariate analysis showed that gross tumor resection and recurrence after surgery were negative factors of the prognosis of PNET patients. Local radiotherapy could improve the prognosis of these patients. Multivariate analysis concluded that gross tumor resection and surgery combined with chemoradiotherapy were independent prognostic factors(P=0.006, P=0.013). Conclusion Surgery combined with chemoradiotherapy is still a recommended multimodal treatment regimen for PNET patients. Recurrence after surgery affects the survival of PNET patients severely, and radical resection of tumor can improve the prognosis of PNET patients treated with surgery.
出处 《解放军医学院学报》 CAS 2016年第5期417-420,共4页 Academic Journal of Chinese PLA Medical School
基金 国家自然科学基金项目(81001042)~~
关键词 原始神经外胚层肿瘤 肿瘤综合治疗 外科手术 预后 primitive neuroectodermal tumor tumor combined treatment surgical procedures prognosis
  • 相关文献

参考文献16

  • 1O' Regan S, Diebler MF, Meunier FM, et al. A Ewing' s sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron[J]. J Neurochem, 1995, 64 ( 1 ) : 69-76.
  • 2Gerber NU, Von Hoff K, Resch A, et al. Treatment of children with central nervous system primitive neuroectodermal tumors/ pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy [J]. Int J Radiat Oncol Biol Phys, 2014, 89 ( 4 ) : 863 -871.
  • 3Jakaeki RI, Burger PC, Kocak M, et al. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy : a report from the Children' s Oneology Group [ J ]. Pediatr Blood Cancer, 2015, 62 ( 5 ) : 776-783.
  • 4张凤春,唐雷,马越,任芳,王红霞,徐迎春.126例外周性原始神经外胚层瘤临床特征及预后因素分析[J].上海交通大学学报(医学版),2012,32(11):1490-1496. 被引量:23
  • 5Rodriguez-Galindo C, Billups CA, Kun LE, et al. Survival after recurrence of Ewing tumors : the St Jude Children' s Research Hospital experience, 1979-1999 [ J ] . Cancer, 2002, 94 ( 2 ) : 561-569.
  • 6Shankar AG, Ashley S, Craft AW, et al. Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma[ J ]. Med Pediatr Oncol, 2003, 40 ( 3 ) : 141-147.
  • 7Cotterill SJ, Ahrens S, Paulussen M, et al. Prognostic factors in Ewing' s tumor of bone : analysis of 975 patients from the European Intergroup Cooperative Ewing' s Sarcoma Study Group [ J ] . J Clin Oncol, 2000, 18 ( 17 ) : 3108-3114.
  • 8Saeedinia S, Nouri M, Alimohammadi M, et al. Primary spinal extradural Ewing' s sarcoma ( primitive neuroectodermal tumor ) : Report of a case and meta-analysis of the reported cases in the literature [J] . Surg Neurol Int, 2012, 3 : 55.
  • 9Bode U, Zimmermann M, Moser O, et al. Treatment of recurrent primitive neuroectodermal tumors ( PNET ) in children and adolescents with high-dose chemotherapy ( HDC ) and stem cell support : results of the HITREZ 97 multieentre trial[ J ]. J Neurooncol, 2014, 120( 3 ): 635-642.
  • 10Ahmed SK, Robinson SI, Okuno SH, et al. Adult ewing sarcoma : survival and local control outcomes in 36 patients with metastatic disease [ J ]. Am J Clin Oncol, 2014, 37 ( 5 ) : 423-429.

二级参考文献16

  • 1崔慧娟,李京华,李欧静,李佩文.原始神经外胚层瘤10年国内文献分析[J].疑难病杂志,2007,6(4):216-219. 被引量:37
  • 2Fraumeni JF, Glass AG. Rarity of Ewing's sarcoma among US. Negro children[J]. Lancet, 1970, I(7462): 366-367.
  • 3Carvajal R, Meyers P. Ewing's sarcoma and primitive neuroectodermal family of annors[J]. Hematol Oncol Clin North Am, 2005, 19(3): 501-525.
  • 4Schulman H, Newman-Heinman N, Kurtzbart E, et al. Thoracoabdominal peripheral primitive neuroectodermal tumors in children: radiological features[J]. Eur Radiol, 2000, 10(10): 1649-1652.
  • 5Kiatsoontorn K, Takami T, Ichinose T, et al. Primary epidural peripheral primitive neuroectodermal tumor of the thoracic spine[J]. Neurol Med Chir(Tokyo), 2009, 49(11): 542-545.
  • 6Ohgaki K, Horiuchi K, Mizutani S, et al. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin[J]. Int J Clin Oncol, 2010, 15(2): 210-214.
  • 7Womer RB, West DC, Krailo MD, et al. A randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing's sarcoma: a report from the Children's Oncology Group[J]. J Clin Oncol, 2012, 30(33): 4148-4154.
  • 8Grier HE, Krailo MD, Tarbell N J, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcomaand primitive neuroectodermal tumor of bone[J]. N Engl J Med, 2003, 348(8): 694-701.
  • 9Luksch R, Tienghi A, Hall KS, et al. Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation[J]. Ann Oncol, 2012, 23( 11): 2970-2976.
  • 10Drabko K, Raciborska A, Bilska K, et al. Consolidation of first- line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma[J]. Bone Marrow Transplant, 2012, 47(12): 1530-1534.

共引文献23

同被引文献16

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部